DK0794770T3 - Transdermalt præparat indeholdende en loratidin-metabolit med antihistaminvirkning - Google Patents

Transdermalt præparat indeholdende en loratidin-metabolit med antihistaminvirkning

Info

Publication number
DK0794770T3
DK0794770T3 DK95941659T DK95941659T DK0794770T3 DK 0794770 T3 DK0794770 T3 DK 0794770T3 DK 95941659 T DK95941659 T DK 95941659T DK 95941659 T DK95941659 T DK 95941659T DK 0794770 T3 DK0794770 T3 DK 0794770T3
Authority
DK
Denmark
Prior art keywords
preparation containing
transdermal preparation
antihistamine action
loratidine
loratidine metabolite
Prior art date
Application number
DK95941659T
Other languages
English (en)
Inventor
Wilfried Fischer
Karin Klokkers
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Application granted granted Critical
Publication of DK0794770T3 publication Critical patent/DK0794770T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95941659T 1994-12-02 1995-12-04 Transdermalt præparat indeholdende en loratidin-metabolit med antihistaminvirkning DK0794770T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4442999A DE4442999A1 (de) 1994-12-02 1994-12-02 Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
PCT/EP1995/004761 WO1996016641A1 (de) 1994-12-02 1995-12-04 Transdermale darreichungsform mit antihistaminisch wirksamen loratidinmetabolit

Publications (1)

Publication Number Publication Date
DK0794770T3 true DK0794770T3 (da) 2001-04-17

Family

ID=6534786

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95941659T DK0794770T3 (da) 1994-12-02 1995-12-04 Transdermalt præparat indeholdende en loratidin-metabolit med antihistaminvirkning

Country Status (11)

Country Link
US (2) US6165498A (da)
EP (1) EP0794770B1 (da)
AT (1) ATE199496T1 (da)
AU (1) AU4301596A (da)
DE (2) DE4442999A1 (da)
DK (1) DK0794770T3 (da)
ES (1) ES2156220T3 (da)
GR (1) GR3035860T3 (da)
PT (1) PT794770E (da)
WO (1) WO1996016641A1 (da)
ZA (1) ZA9510234B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4442999A1 (de) * 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
AU776837B2 (en) * 1997-02-07 2004-09-23 Sunovion Pharmaceuticals Inc. Lactose-free non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
CA2288726C (en) * 1997-04-25 2008-04-01 Schering-Plough Kabushiki Kaisha Eyedrops containing a loratadine metabolite
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
WO2001045668A2 (en) 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
DE60141596D1 (de) 2000-10-23 2010-04-29 Euro Celtique Sa Transdermales system zur verabreichung von loratadin und dessen verwendung
DE10360592A1 (de) * 2003-12-19 2005-07-28 Beiersdorf Ag Pflastersystem zur Verabreichung von Antihistaminika
US20090082385A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched desloratidine
KR102081925B1 (ko) 2012-08-29 2020-02-26 엘지전자 주식회사 디스플레이 디바이스 및 스피치 검색 방법
DE202018106738U1 (de) * 2018-11-27 2018-12-06 Amoena Medizin-Orthopädie-Technik GmbH Kompressions-Büstenhalter zur postoperativen Versorgung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US4910205A (en) * 1988-05-02 1990-03-20 Schering Corporation Transdermal delivery of loratadine
DE4442999A1 (de) * 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten

Also Published As

Publication number Publication date
PT794770E (pt) 2001-08-30
WO1996016641A1 (de) 1996-06-06
US6395297B1 (en) 2002-05-28
DE59509084D1 (de) 2001-04-12
AU4301596A (en) 1996-06-19
ZA9510234B (en) 1996-09-02
ATE199496T1 (de) 2001-03-15
US6165498A (en) 2000-12-26
EP0794770A1 (de) 1997-09-17
ES2156220T3 (es) 2001-06-16
EP0794770B1 (de) 2001-03-07
DE4442999A1 (de) 1996-06-05
GR3035860T3 (en) 2001-08-31

Similar Documents

Publication Publication Date Title
DK0794770T3 (da) Transdermalt præparat indeholdende en loratidin-metabolit med antihistaminvirkning
NO307644B1 (no) Transdermalt, terapeutisk system med krystalliseringsinhibitor
ATE200028T1 (de) Transdermale abgabe vorrichtung
GR890100838A (el) Νέα ?εραπευτικώς δραστική ένωσις και μέ?οδος για την παραγωγή της.
NO2013002I1 (no) Aklidinium haogenid (Aklidinium bromid)
DE68920200T2 (de) Anzeigetafel mit aktiver Matrix.
NO20053106D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse.
DE60106235D1 (de) Mit medikamenten gefülltes transdermales reservoir und verfahren zu seiner herstellung
MY134888A (en) Optically active isomers of ketotifen and therapeutically active metabolites thereof
NZ332215A (en) Transdermally administered dextromethorphan as antitussive agent
HK1050998A1 (en) Member for application of ointment and ointment patch employing the same
EP0285181A3 (en) Etofenamate-containing adhesive tape
FI942502A0 (fi) Kasvolevyn kaksiasentoisella kytkentärenkaalla varustettu kaksiosainen ostomialaite
YU45395A (sh) Novo hemijsko jedinjenje, njegovo pripremanje i njegova primena kao leka
FR2649586B1 (fr) Dispositif d'epandage destine notamment aux granules antilimaces
EP0948961A3 (de) Calciumhaltige Brausetablette mit einem Antihistaminikum als Wirkstoff
IL146917A0 (en) Composition containing angiotensin ii antagonist, boric acid and ethylenediamine tetraacetic acid
IT216578Z2 (it) Capsula piezoceramica per apparecchi telefonici.
DE9317034U1 (de) Aufzuhängende, versandfähige Schaupackung
ES456283A1 (es) Un procedimiento para la obetencion de 2,5-dimetil-benzo (b)tieno (2,3-f) morfano.
賞報告 et al. SkSZ
ES2141044A1 (es) Terapia con oxibutinina.
ES556216A0 (es) Procedimiento de obtencion de una composicion de copolimero octobloque biologicamente activo.
DK302990A (da) Fremgangsmaade til nedbrydning af metal-cyanidkomplekser under anvendelse af mikrobielle enzymer
KR940026817U (ko) 오, 폐수 처리용 토양균군 필렛 유닛 및 이를 이용한 토양균군 배양장치